πŸ‡ΊπŸ‡Έ FDA
Patent

US 6717017

Total synthesis of antitumor acylfulvenes

expired A61PA61P35/00

Quick answer

US patent 6717017 (Total synthesis of antitumor acylfulvenes) held by The Regents of the University of California expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00